More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

GeneDx is targeting a big market for its genetic testing: every newborn baby. The 24-old-company is developing a plan to make the testing common at birth.

The largest study to date to analyse millions of both genetic and patient records on the long-term health conditions of later life has identified opportunities for new ways to prevent and treat ...